CRGO:NASDAQFreightos Limited Analysis
Data as of 2026-06-11 - not real-time
$1.71
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Freightos is trading below its short‑term moving averages, with the price under the 20‑day SMA and just above the identified support level. Technical momentum is weak – the MACD is in a bearish configuration and the RSI sits near the low‑40s, hinting at modest oversold pressure. The recent Q1 2026 results showed revenue edging up only 3% YoY and transaction growth falling short of the 20% target due to Middle‑East trade disruptions, while adjusted EBITDA remained a multi‑million‑dollar loss. Despite these challenges, the company holds a solid cash buffer relative to its modest debt, and its price‑to‑book and price‑to‑sales multiples sit well below industry averages, suggesting a valuation gap. However, high beta and 30‑day volatility above 60% underscore a volatile price profile.
In summary, the stock presents a short‑term technical pullback risk, a medium‑term upside catalyst if transaction growth rebounds, and a longer‑term play on the broader digital freight transformation.
In summary, the stock presents a short‑term technical pullback risk, a medium‑term upside catalyst if transaction growth rebounds, and a longer‑term play on the broader digital freight transformation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and RSI near oversold levels
- Price hovering just above key support
- Recent earnings miss on transaction growth
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Valuation gap relative to industry multiples
- Strong cash position versus low debt
- Potential rebound in transaction volume as Middle‑East disruptions ease
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic position as a vendor‑neutral digital freight platform
- Long‑term industry tailwinds toward freight digitalization
- Scalable SaaS offerings that could improve margins over time
Key Metrics & Analysis
Financial Health
Revenue Growth3.00%
Profit Margin-65.65%
P/E Ratio-17.1
ROE-43.77%
ROA-18.38%
Debt/Equity6.13
P/B Ratio2.4
Op. Cash Flow$-13621000
Free Cash Flow$-5565500
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI39.4
Support$1.57
Resistance$2.36
MA 20$1.92
MA 50$1.91
MA 200$2.51
MACDBearish
VolumeIncreasing
Fear & Greed Index84.43
Valuation
Target Price$2.80
Upside/Downside63.74%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.81
Volatility61.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKYOU
Clear Secure, Inc.
STOCKABCL
AbCellera Biologics Inc.
STOCKWETH
Wetouch Technology Inc.
STOCKSOPA
Society Pass Incorporated
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.